Publications by authors named "Britney Barrera"

Article Synopsis
  • The study assessed the safety of at-home ocrelizumab infusions for multiple sclerosis patients, focusing on infusion-related reactions (IRRs) and patient satisfaction.* -
  • It involved 99 participants who received a 600-mg infusion, with a noted IRR incidence rate of 25.3%, while most adverse events reported were mild or moderate.* -
  • Patients expressed higher satisfaction and confidence in the home infusion process compared to previous experiences at infusion centers, highlighting the feasibility of this approach.*
View Article and Find Full Text PDF